Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07054983Not ApplicableEnrolling By Invitation

Parent Tube Weaning Interviews

Role: collaborator

NCT07203157Not ApplicableNot Yet Recruiting

HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms

Role: collaborator

NCT05690230Not ApplicableCompleted

Improving Patient Experience: BMBA

Role: collaborator

NCT03399331Phase 1Completed

Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy

Role: collaborator

NCT02976103Not ApplicableCompleted

Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket

Role: collaborator

NCT02441075Not ApplicableCompleted

70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014

Role: collaborator

All 6 trials loaded